Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer
|
June 3, 2025
Raf kinase inhibitor protein modulator of gut microbiota and immunotherapy responses in cancer
Giuseppe Palma, Francesca Bruzzese, Concetta Meo, et al.
Cancer Treatment and Research
|
October 12, 2013
New perspective for an old antidiabetic drug: metformin as anticancer agent
Alessandra Leone, Elena Di Gennaro, Francesca Bruzzese, et al.
Drug Discovery Today
|
April 25, 2015
Pathophysiologically relevant in vitro tumor models for drug screening
Viswanath Das, Francesca Bruzzese, Petr Konečný, et al.
Journal of Translational Medicine
|
April 21, 2023
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
Concetta Meo, Giuseppe Palma, Francesca Bruzzese, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
January 29, 2008
Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents
Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, et al.
Molecular Cancer Therapeutics
|
November 6, 2009
Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
Francesca Bruzzese, Monia Rocco, Silvia Castelli, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
December 1, 2017
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
Federica Iannelli, Rita Lombardi, Maria R Milone, et al.
Journal of Cellular Physiology
|
October 27, 2018
Novel pathways involved in cisplatin resistance identified by a proteomics approach in non-small-cell lung cancer cells
Maria Rita Milone, Rita Lombardi, Maria Serena Roca, et al.
Nutrients
|
February 11, 2023
Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness-A Practical Preventing Recommendation and Therapies
Edoardo Tacconi, Giuseppe Palma, Davide De Biase, et al.
Journal of Cellular Physiology
|
June 11, 2011
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
Francesca Bruzzese, Alessandra Leone, Monia Rocco, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Biochimica Et Biophysica Acta. Reviews on Cancer
|
June 3, 2025
Raf kinase inhibitor protein modulator of gut microbiota and immunotherapy responses in cancer
Giuseppe Palma, Francesca Bruzzese, Concetta Meo, et al.
Cancer Treatment and Research
|
October 12, 2013
New perspective for an old antidiabetic drug: metformin as anticancer agent
Alessandra Leone, Elena Di Gennaro, Francesca Bruzzese, et al.
Drug Discovery Today
|
April 25, 2015
Pathophysiologically relevant in vitro tumor models for drug screening
Viswanath Das, Francesca Bruzzese, Petr Konečný, et al.
Journal of Translational Medicine
|
April 21, 2023
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatment
Concetta Meo, Giuseppe Palma, Francesca Bruzzese, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
January 29, 2008
Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents
Alfredo Budillon, Elena Di Gennaro, Francesca Bruzzese, et al.
Molecular Cancer Therapeutics
|
November 6, 2009
Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
Francesca Bruzzese, Monia Rocco, Silvia Castelli, et al.
Recent Patents on Anti-Cancer Drug Discovery
|
December 1, 2017
Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins
Federica Iannelli, Rita Lombardi, Maria R Milone, et al.
Journal of Cellular Physiology
|
October 27, 2018
Novel pathways involved in cisplatin resistance identified by a proteomics approach in non-small-cell lung cancer cells
Maria Rita Milone, Rita Lombardi, Maria Serena Roca, et al.
Nutrients
|
February 11, 2023
Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness-A Practical Preventing Recommendation and Therapies
Edoardo Tacconi, Giuseppe Palma, Davide De Biase, et al.
Journal of Cellular Physiology
|
June 11, 2011
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
Francesca Bruzzese, Alessandra Leone, Monia Rocco, et al.
Page
of 5